<DOC>
	<DOCNO>NCT00541242</DOCNO>
	<brief_summary>The study compare safety efficacy Bimatoprost Latanoprost patient glaucoma ocular hypertension</brief_summary>
	<brief_title>Safety Efficacy Bimatoprost Compared With Latanoprost Patients With Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Ocular hypertension chronic glaucoma Patient require IOPlowering therapy eye Uncontrolled medical condition Hypersensitivity study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>